Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2 triggered relapse of multiple sclerosis
Josef Finsterer
Clinical Neurology and Neurosurgery (2022) Vol. 215, pp. 107210-107210
Open Access | Times Cited: 18

Showing 18 citing articles:

Impact of COVID-19 and vaccination on multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD)
Metha Apiwattanakul, Chawarat Ounmuang, Saharat Aungsumart
Multiple Sclerosis and Related Disorders (2025) Vol. 95, pp. 106316-106316
Closed Access
COVID-19 has no impact on disease activity, progression and cognitive performance in people with multiple sclerosis: a 2-year study
Federico Montini, Agostino Nozzolillo, Nicolò Tedone, et al.
Journal of Neurology Neurosurgery & Psychiatry (2023), pp. jnnp-332073
Open Access | Times Cited: 13
COVID-19 and the risk of CNS demyelinating diseases: A systematic review
Itay Lotan, Shuhei Nishiyama, Giovanna S. Manzano, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 20
New‐onset pemphigus foliaceus following SARS‐CoV‐2 infection and unmasking multiple sclerosis: A case report
Fatemeh Mohaghegh, Parvaneh Hatami, Arezoo Refaghat, et al.
Clinical Case Reports (2022) Vol. 10, Iss. 6
Open Access | Times Cited: 13
Characteristics and management of multiple sclerosis patients during the Omicron era: is there a concern about the MS course in the face of the new variant of COVID-19?
Sepideh Paybast, Mohammad Amin Habibi, Abdorreza Naser Moghadasi
Neurological Sciences (2022) Vol. 44, Iss. 2, pp. 659-665
Open Access | Times Cited: 11
COVID-19 and autoimmune diseases of the nervous system — an update
Natalia Morawiec, Bożena Adamczyk, Monika Adamczyk‐Sowa
Neurologia i Neurochirurgia Polska (2023) Vol. 57, Iss. 1, pp. 77-89
Open Access | Times Cited: 5
Incidence of multiple sclerosis relapses and pseudo-relapses following COVID-19 vaccination
Amir Labani, Scott Chou, Kasra Kaviani, et al.
Multiple Sclerosis and Related Disorders (2023) Vol. 77, pp. 104865-104865
Closed Access | Times Cited: 5
The Potential Role of SARS-CoV-2 Infection and Vaccines in Multiple Sclerosis Onset and Reactivation: A Case Series and Literature Review
Eleonora Tavazzi, Anna Pichiecchio, Elena Colombo, et al.
Viruses (2023) Vol. 15, Iss. 7, pp. 1569-1569
Open Access | Times Cited: 5
A case of early disease rebound after fingolimod discontinuation in a patient with multiple sclerosis and SARS-CoV-2 infection
Beatrice Giovannini, Deborah Panelli, Francesca Bianchi, et al.
Neurological Sciences (2024) Vol. 45, Iss. 6, pp. 2423-2426
Closed Access | Times Cited: 1
Temelimab for MS and SARS-CoV-2: Could it be a double-edged blessing?
Dimitra S. Mouliou, Efthimios Dardiotis
Multiple Sclerosis and Related Disorders (2022) Vol. 64, pp. 103938-103938
Open Access | Times Cited: 6
One-year self-reported neurological sequelae in older COVID-19 survivors
Li Jiang, Xiaoyu Liu, Xiaoqin Yan, et al.
Ageing and Neurodegenerative Diseases (2022) Vol. 2, Iss. 3, pp. 10-10
Open Access | Times Cited: 4
Humoral immune response and safety of Sars-Cov-2 vaccine in people with multiple sclerosis
Seyedeh Sadigheh Hamzavi, Rosemina Bahrololoom, Sepideh Saeb, et al.
BMC Immunology (2024) Vol. 25, Iss. 1
Open Access
Case Report: New-onset relapsing-remitting multiple sclerosis with positive Uhthoff phenomenon after second BNT162b2 dose
Josef Finsterer, Neil M. D’Souza
F1000Research (2024) Vol. 13, pp. 943-943
Open Access
Multiple sclerosis incidence in Al-Madinah Al-Munawwarah in Saudi Arabia before and after the COVID-19 pandemic: a retrospective cross-sectional study
Yousra H. Jaaoini, Raghad A. Fallatah, Rawan S. Alsuhaymi, et al.
International Journal of Community Medicine and Public Health (2024) Vol. 11, Iss. 12, pp. 4645-4653
Open Access
Central Nervous System Neuroimmunologic Complications of COVID-19
Kathryn B. Holroyd, Sarah Conway
Seminars in Neurology (2023) Vol. 43, Iss. 02, pp. 229-250
Closed Access | Times Cited: 1
Occurrence and Risk Factors of Relapse Activity after Vaccination against COVID-19 in People with Multiple Sclerosis: 1-Year Follow-Up Results from a Nationwide Longitudinal Observational Study
Firas Fneish, Niklas Frahm, Melanie Peters, et al.
Vaccines (2023) Vol. 11, Iss. 12, pp. 1859-1859
Open Access | Times Cited: 1
Relationship between SARS-COV-2 And autoimmune neurological diseases
A. I. Vlasenko, O. A. Portik, G. N. Bisaga, et al.
Journal Infectology (2022) Vol. 14, Iss. 2, pp. 65-72
Open Access | Times Cited: 1
Dystonia as a complication of COVID-19 vaccinations is not as rare as portrayed
Fúlvio A. Scorza, Carla A. Scorza, Ana C. Fiorini, et al.
Clinical Neurology and Neurosurgery (2022) Vol. 222, pp. 107447-107447
Open Access | Times Cited: 1
Page 1

Scroll to top